Anaplasma marginale infection with persistent high-load bacteremia induces a dysfunctional memory CD4+ T lymphocyte response but sustained high IgG titers

Clinical and Vaccine Immunology

Volumn 17, Issue 12, 2010, Pages 1881-1890

  Han, Sushan ^a   Norimine, Junzo ^a   Brayton, Kelly A ^a   Palmer, Guy H ^a   Scoles, Glen A ^a   Brown, Wendy C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; CATTLE; CD4+ T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNIZATION; MEMORY T LYMPHOCYTE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEOBACTERIA;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMALS; ANTIBODIES, BACTERIAL; BACTEREMIA; BLOOD; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; IMMUNOGLOBULIN G; SPLEEN; TIME FACTORS;

EID: 78649864852     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00257-10     Document Type: Article

References (57)

1. + T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale. J. Immunol. 174:6702-6715.
2. + T cell epitopes are evenly distributed in conserved and hypervariable regions (HVR), whereas linear B-cell epitopes are predominantly located in the HVR. Infect. Immun. 72:7360-7366.
3. Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7:875-888.
4. Bitsaktsis, C., N. Bisweswar, R. Racine, K. C. MacNamara, and G. M. Winslow. 2007. T-cell-independent humoral immunity is sufficient for protection against fatal intracellular Ehrlichia infection. Infect. Immun. 75:4933-4941.
5. Brayton, K. A., P. F. Meeus, A. F. Barbet, and G. H. Palmer. 2003. Simultaneous variation of the immunodominant outer membrane proteins, MSP2 and MSP3, during Anaplasma marginale persistence in vivo. Infect. Immun. 71:6627-6632.
6. Brayton, K. A., D. P. Knowles, T. C. McGuire, and G. H. Palmer. 2001. Efficient use of a small genome to generate antigenic diversity in tick-borne ehrlichial pathogens. Proc. Natl. Acad. Sci. U. S. A. 98:4130-4135.
7. + T lymphocyte epitopes that elicit variant-specific proliferative and IFN-γ responses in MSP2 vaccinates. J. Immunol. 170:3790-3798.
8. + T lymphocyte epitopes that elicit strong recall responses. J. Immunol. 166:1114-1124.
9. + T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains. Infect. Immun. 69:6853-6862.
10. + T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect. Immun. 66:5406-5413.
11. + T-lymphocyte clones from protectively immunized cattle is diverse and includes major surface protein 2 (MSP-2) and MSP-3. Infect. Immun. 66:5414-5422.
12. + T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 9:1035-1041.
13. Dalton, D. K., L. Haynes, C. Q. Chu, S. L. Swain, and S. Wittmer. 2000. Interferon-γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J. Exp. Med. 192:117-122.
14. Dietsch, K. W., S. A. Lukehart, and J. R. Stringer. 2009. Common strategies for antigenic variation by bacterial, fungal, and protozoan pathogens. Nat. Rev. Microbiol. 7:493-503.
15. Eid, G., D. M. French, A. M. Lundgren, A. F. Barbet, T. F. McElwain, and G. H. Palmer. 1996. Expression of major surface protein 2 antigenic variants during acute Anaplasma marginale rickettsemia. Infect. Immun. 64:836-841.
16. Estes, D. M., N. M. Closser, and G. K. Allen. 1994. IFN-γ stimulates IgG2 production from bovine B cells costimulated with anti-mu and mitogen. Cell. Immunol. 154:287-295.
17. Freeman, G. J., E. J. Wherry, R. Ahmed, and A. H. Sharpe. 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203:2223-2227.
18. French, D. M., W. C. Brown, and G. H. Palmer. 1999. Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia. Infect. Immun. 67:5834-5840.
19. Futse, J. E., K. A. Brayton, S. D. Nydam, and G. H. Palmer. 2009. Generation of antigenic variants via gene conversion: evidence for recombination fitness selection at the locus level in Anaplasma marginale. Infect. Immun. 77:3181-3187.
20. Futse, J. E., M. W. Ueti, D. P. Knowles, and G. H. Palmer. 2003. Transmission of Anaplasma marginale by Boophilus microplus: retention of vector competence in the absence of vector-pathogen interaction. J. Clin. Microbiol. 41:3829-3834.
21. Goff, W. L., W. C. Johnson, C. R. Wyatt, and C. W. Cluff. 1996. Assessment of bovine mononuclear phagocytes and neutrophils for induced L-arginine-dependent nitric oxide production. Vet. Immunol. Immunopathol. 55:45-62.
22. + T cells following infection represents a strategy of immune evasion and persistence for Anaplasma marginale. J. Immunol. 181:7759-7769.
23. Horneff, M. W., M. J. Wick, M. Rhen, and S. Normark. 2002. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 3:1033-1040.
24. Jameson, S. C., and D. Masopust. 2009. Diversity of T cell memory: an embarrassment of riches. Immunity 31:859-871.
25. + T lymphocytes: a mechanism of immune unresponsiveness in filariasis. Eur. J. Immunol. 32:858-867.
26. + T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle. J. Virol. 83:3626-3636.
27. + T cell responses during persistent virus infection. J. Immunol. 174:7950-7960.
28. Klenerman, P., and A. Hill. 2005. T cells and viral persistence: lessons from diverse infections. Nat. Rev. Immunol. 6:873-879.
29. Knowles, D. P., S. Torioni de Echaide, G. H. Palmer, T. C. McGuire, D. Stiller, and T. F. McElwain. 1996. Antibody against an Anaplasma marginale MSP5 epitope common to tick and erythrocyte stages identifies persistently infected cattle. J. Clin. Microbiol. 34:2225-2230.
30. + T-cell immunodominant Anaplasma marginale major surface protein 2 stimulates γδ T-cell clones that express unique T-cell receptors. J. Leukoc. Biol. 77:199-208.
31. Lanzavecchia, A., and F. Sallusto. 2009. Human B cell memory. Curr. Opin. Immunol. 21:298-304.
32. + T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptosis signals. J. Immunol. 179:939-949.
33. Lopez, J. E., P. A. Beare, R. A. Heinzen, J. Norimine, K. K. Lahmers, G. H. Palmer, and W. C. Brown. 2008. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation. J. Immunol. Methods 332:129-144.
34. Lopez, J. E., W. F. Siems, K. A. Brayton, G. H. Palmer, T. C. McGuire, and W. C. Brown. 2005. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect. Immun. 73:8109-8118.
35. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14:617-629.
36. Mebius, R. E., and G. Kraal. 2005. Structure and function of the spleen. Nat. Rev. Immunol. 5:606-616.
37. Meeus, P. F., M. A. Brayton, G. H. Palmer, and A. F. Barbet. 2003. Conservation of gene conversion mechanism in two distantly related paralogues of Anaplasma marginale. Mol. Microbiol. 47:633-643.
38. Morrison, L. J., L. Marcello, and R. McCulloch. 2009. Antigenic variation in the African trypanosome: molecular mechanisms and phenotypic complexity. Cell. Microbiol. 11:1724-1734.
39. + T-lymphocyte responses. Immunogenetics 57:750-762.
40. Palmer, G. H., and K. A. Brayton. 2007. Gene conversion is a convergent strategy for pathogen antigenic variation. Trends Parasitol. 23:408-413.
41. Palmer, G. H., W. C. Brown, and F. R. Rurangirwa. 2000. Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginale. Microbes Infect. 2:1-10.
42. Palmer, G. H., F. R. Rurangirwa, K. M. Kocan, and W. C. Brown. 1999. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol. Today 15:281-286.
43. Palmer, G. H., and T. F. McElwain. 1995. Molecular basis of vaccine development against anaplasmosis and babesiosis. Vet. Parasitol. 57:233-253.
44. Palmer, G. H., and T. C. McGuire. 1984. Immune serum against Anaplasma marginale initial bodies neutralizes infectivity for cattle. J. Immunol. 133:1010-1015.
45. Park, Y. H., Y. S. Joo, J. Y. Park, J. S. Moon, S. H. Kim, N. H. Kwon, J. S. Ahn, W. C. Davis, and C. J. Davies. 2004. Characterization of lymphocyte subpopulations and major histocompatibility complex haplotypes of mastitis-resistant and susceptible cows. J. Vet. Sci. 5:29-39.
46. Tebele, N., T. C. McGuire, and G. H. Palmer. 1991. Induction of protective immunity using Anaplasma marginale initial body membranes. Infect. Immun. 59:3199-3204.
47. Ueti, M. W., J. O. Reagan, D. P. Knowles, and G. A. Scoles. 2007. Identification of midgut and salivary glands as specific and distinct barriers to efficient tick-borne transmission of Anaplasma marginale. Infect. Immun. 75:2959-2964.
48. van Eijk, M. J., J. A. Stewart-Haynes, and H. A. Lewin. 1992. Extensive polymorphism of the BoLA-DRB3 gene distinguished by PCR-RFLP. Anim. Genet. 23:483-496.
49. Varma, S., and A. M. Shatry. 1980. A technique for partial marsupialization of the spleen in calves. Vet. Rec. 106:127-128.
50. + T cells do not develop during chronic viral infection. Proc. Natl. Acad. Sci. U. S. A. 45:16004-16009.
51. Wikel, S. K. 1999. Tick modulation of host immunity: an important factor in pathogen transmission. Int. J. Parasitol. 29:851-859.
52. + T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170:2046-2052.
53. Woolard, M. D., and J. A. Frelinger. 2008. Outsmarting the host: bacteria modulating the immune response. Immunol. Res. 41:188-202.
54. Wykes, M. N., Y. H. Zhou, X. Q. Liu, and M. F. Good. 2005. Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J. Immunol. 175:2510-2516.
55. + T cells in malaria infection. J. Exp. Med. 195:881-892.
56. + T cells endowed with proliferative capacity. J. Exp. Med. 198:1909-1922.
57. Zhuang, Y., J. E. Futse, W. C. Brown, K. A. Brayton, and G. H. Palmer. 2007. Maintenance of antibody to pathogen epitopes generated by segmental gene conversion is highly dynamic during long-term persistent infection. Infect. Immun. 75:5185-5190.